A benzodiazepine antagonist does not alter the course of hepatic encephalopathy or neural ?-aminobutyric acid (GABA) binding

Advances in hepatic encephalopathy and urea cycle diseases

D. R. Triger · Clinical Nutrition · 1985 · 147 citations

Medicine, Pathobiology, Pathology +14

Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure

Mark L. Bassett, Kevin D. Mullen, Phil Skolnick et al. · Gastroenterology · 1987 · 146 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Experimental Hepatic Encephalopathy: Changes in the Binding of γ-Aminobutyric Acid

Mario Baraldi, Maria Luisa Zeneroli · Science · 1982 · 127 citations

Life Sciences, Neurobiology, Neuroscience +17

Supersensitivity of Benzodiazepine Receptors in Hepatic Encephalopathy Due to Fulminant Hepatic Failure in the Rat: Reversal by a Benzodiazepine Antagonist

Mario Baraldi, Maria Luisa Zeneroli, E. Ventura et al. · Clinical Science · 1984 · 126 citations

Medicine, Neuroscience, Pharmacology +16

Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure.

D. F. Schafer, Jeffrey M. Fowler, Peter J. Munson et al. · PubMed · 1983 · 109 citations

Medicine, Pharmacology, Molecular Pharmacology +11